cannabis marijuana cbd cannabidiol thc

On Monday, June 25, 2018, the United States Food and Drug Administration announced the approval of the first marijuana-based prescription medication in the US. The drug, called Epidiolex, is a plant-derived oral solution of cannabidiol (CBD). CBD, a chemical derived from cannabis, is a cannabinoid that does not produce psychoactive effects when consumed.

Produced by UK-based firm GW Pharmaceuticals PLC,Epidiolex was approved to treat patients aged two and older who suffer from Lennox-Gastaut syndrome and Dravet syndrome, both rare and severe forms of epilepsy that can develop in early childhood. This move also marks the FDA